The Latest at Forbes Monaco

Forbes Now


Stem Cell Mesoblast
Innovation

Clinical Trials Of Mesoblast’s Stem Cell Treatment For COVID-19 Set To Begin Soon


Melbourne-based biotech company Mesoblast announced earlier this week that it’s begun enrolling up to 300 patients for a randomized, controlled study of its stem cell therapy remestemcel-L in the treatment of COVID-19 patients experiencing acute respiratory distress syndrome. Over 20 hospitals will participate in the study, which is anticipated to last 3-4 months. The announcement…

Blue Economy

Monaco Champions The Blue Economy


How our oceans are driving the European economy through innovation and sustainable growth. The so-called oyster luge, slurping the brine of the bivalve followed by a smoky sip of single malt scotch, has become something of a stealth hit among elite bars. But that’s not the reason Glenmorangie, the Scottish whisky distiller owned by Louis Vuitton Moet Hennessy (LVMH), started sending divers…

More from Science


Opera Gallery Monaco